Navigation Links
Intervention in infants with cystic fibrosis key to slowing progression
Date:12/4/2008

Early detection of lung disease in cystic fibrosis (CF), combined with aggressive treatment in infants, may be the key to controlling the progression of the disease, according to a recent study. New research shows that contrary to previous scientific opinion, progressive lung damage in CF patients can begin as early as infancy even though lung function shortly after diagnosis is normal.

"We might be able to stop some of the lung function reduction we're identifying in the first months of life," said Dr. Sarath Ranganathan, Ph.D., consultant respiratory physician at the Royal Children's Hospital in Melbourne, and lead author of the paper, which appeared in the second issue for December of the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.

"We don't know what's going to work, but we have to target those patients in the first six months of life if we're going to be effective," added Dr. Ranganathan.

In the Australian study, 68 infants with CF were compared to 49 infants without the disease. The children were between six weeks and 30 months of age. Forced expiratory volume (FEV) measurements were obtained for the children at baseline, and 16 of the children with CF were measured again one year later. FEV was equivalent for all children both with and without CF at baseline. But by six months of age, the mean FEV score was significantly lower in infants with CF compared to controlsand the deficit increased with each month of age. "This finding indicates that lung function declines sooner than previously thought," said Dr. Ranganathan.

The study also found that diminished lung function occurred even in the absence of clinical symptoms and irrespective of CF genotype. But, notably, infants measured soon after birth and within the first six months of life had normal lung function. Newborn screening for CF has been in existence in Australia for nearly 30 years, but was introduced only r
'/>"/>

Contact: Keely Savoie
ksavoie@thoracic.org
212-315-8620
American Thoracic Society
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Posit Science Invited to Speak at Johns Hopkins University About Cutting Edge Cognitive Training Interventions
2. Elseviers New Imaging Consult Features In-Depth, Authoritative Information For Diagnostic and Interventional Imaging and Procedures in a Single Online Resource
3. HealthMedia Announces Industrys First Individually Tailored Physical Activity Intervention and Other Innovative New Program Features
4. Home-based diet and exercise intervention improves elderly cancer survivors physical function
5. Intervention program boosts survival in breast cancer patients
6. Psychological interventions associated with breast cancer survival
7. Rubenstein Public Relations to Launch National Campaign for The American Society of Interventional Pain Physicians
8. New model developed to estimate radiation skin doses during CT-guided interventional procedures
9. Interventions to Promote Breast-Feeding Succeed
10. The future of interventional cardiology presented at TCT 2008
11. 2nd International Conference, Signs of Autism in Infants: Changing Outcomes Through Early Identification and Intervention, October 11 & 12, 2008; Unique and Critical Event

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/7/2009)...id A. Cook (GA), Louis J. Goodman (TX), Palmer P. ...ICAGO, Nov. 7 The Ameri... medical society executive leaders with achievemen... and ideals of the medical profession. The awards ...ing meeting in Houston. ,, (Logo: http://www...
(Date:11/7/2009)...USNewswire/ -- The U.S. bishops November 7 urged m... the Stupak-Ellsworth Amendment to the health care...Dahlkemper-Lipinski-Smith Amendment will keep in p...onscience protections in the Affordable Health Car...he letter was signed by Cardinal Justin Rigali, ch...
(Date:11/7/2009)...roblem across the U.S. , , SATURDAY, Nov. ...our-year colleges do it regularly (and, it,s not s... or more alcoholic drinks at a sitting. , "People ...aid Jenny Hwang, associate dean of students and di...versity on Long Island, N.Y. In fact, she said, he...
(Date:11/6/2009)..., Nov. 6 /PRNewswire-FirstCall/ - Cardiome Pharma ...that it will report financial results for the thir...of Monday, November 9, 2009. Cardiome will hold a ...(6:00am Pacific) on that day to discuss the result...16-695-7806 or 888-789-9572 and reference conferen...
(Date:11/6/2009)...n (NYSE: CNC ) today announced that it will prese... next few weeks. ,, Next week, at the Credit Suiss...ovember 11-13, 2009, at the Arizona Biltmore Resor...ay, November 11th at 4:30 p.m. Mountain Time. Inve...ene,s presentation at: http://w.on24.com/r.htm?e...
Breaking Medicine News(10 mins):Health News:AMA Honors Medical Society Executives 2Health News:Bishops Urge Passage of Stupak-Ellsworth Anti-Abortion Amendment for Health Reform Bill 2Health News:Binge Drinking Puts the Brain, and Life Itself, at Risk 2Health News:Binge Drinking Puts the Brain, and Life Itself, at Risk 3Health News:Cardiome to Release Third Quarter Results 2Health News:Cardiome to Release Third Quarter Results 3Health News:Centene Corporation to Present at Upcoming Healthcare Conferences 2
...ony Ohotto, a physician,with Signature Hospice, ha...ttoo. "Limited life expectancy is no reason not to...e wrote the order as a health clearance, a,stateme... emotional decline in their young patient with a n...
...Long-Time Twin Cities Health Care ...rk G. Mishek, a Minnesota native,with extensive ex... Monday,as President and CEO of Hazelden, the nati...o: http://www.newscom.com/cgi-bin/prnh/20080825/A...
...ecting the expanding,scope of chronic disease care...environmental factors on health care systems and p...blisher Mary Ann Liebert Inc. have renamed,the pee... (Volume 11, Number 4). With the new name comes a,...
...n with certain genotype more affected, study finds...reast-feeding moms who take medicines containing c...eir infant, new Canadian research suggests. , The ... -- possibly harming the infant,s central nervous ...
...ases the risk of developing cancers of the respira...ysis, which the authors say is the first prospecti...rs in the October 1, 2008 issue of CANCER, a pee...rning incensewhich is made of plant materials mixe...
...enefit Group, LLC announces iCan Insurance, LLC (&...w offering major medical health plans from Avalon ...aton, FL (PRWEB) August 24, 2008 -- iCan Benefit G...re, Inc. http://www.icanbenefit.com/majorMedical/...
Other Medicine News:Health News:Signature Hospice Team Grants Patient's Unusual Wish 2Health News:Mark G. Mishek Is New President and CEO of Hazelden 2Health News:Disease Management Journal Changes Name and Expands Focus to Population Health Management 2Health News:Taking Codeine While Breast-Feeding May Harm Infant 2Health News:Taking Codeine While Breast-Feeding May Harm Infant 3Health News:Burning incense increases risk of respiratory tract cancers 2Health News:iCan Benefit Group, LLC Announces: Major Medical Division Now Offers Avalon Healthcare Products 2
(Date:11/6/2009)...anitoba, Nov. 6 With his proposed ...s set his sights on cutting name-brand prescriptio...ho fall into the "Part D" coverage gap, universall...bout the potential cost-cutting and feel it,s a pr...he most powerful lobbyists want a revised program ...
(Date:11/6/2009)...IANGLE PARK, N.C., Nov. 6 Chimerix...ly-available antiviral therapeutics to address lif...evelopment of the company,s lead antiviral compoun...and the Global Health Security Initiative (GHSI). ...developed for the treatment of smallpox, as well a...
(Date:11/6/2009)...Nov. 6 NexBio Inc., in collaborati...rol and Prevention (CDC), St. Louis University, an... publication of two articles in the peer-reviewed ...gest that DAS181 (Fludase ® ) may play a pote...ntion of the Pandemic Influenza A(H1N1) and drug-r...
Breaking Medicine Technology:Obama Healthcare Reforms Fall Short, but Betterthanmedicare.com Closes the 'Donut Hole' 2Obama Healthcare Reforms Fall Short, but Betterthanmedicare.com Closes the 'Donut Hole' 3Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 2Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 3NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 2NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 3NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 4Michael J Fox Foundation Awards 243 8 Million To Drive Nine Industry Partnerships For Pre Clinical Parkinsons Drug Development 52311 1Michael J Fox Foundation Awards 243 8 Million To Drive Nine Industry Partnerships For Pre Clinical Parkinsons Drug Development 52311 2Michael J Fox Foundation Awards 243 8 Million To Drive Nine Industry Partnerships For Pre Clinical Parkinsons Drug Development 52311 3Studies Show Genetic Activity of Antioxidants 52308 1Studies Show Genetic Activity of Antioxidants 52308 2Studies Show Genetic Activity of Antioxidants 52308 3Winners of the C Everett Koop Health Project Award Announced 52305 1Winners of the C Everett Koop Health Project Award Announced 52305 2
...ging Results for a Potential New Front-Line Treatm...AMBRIDGE, Mass., June 2 Genzyme Corp.,(Nasdaq: G...-enrolled,pivotal, phase 2 study examining the saf...s a single agent in previously untreated, older ad... who are unlikely to benefit,from conventional "7+...
...esponse Trends Suggest Improved Efficacy with High... - Dose Escalation Ongoing -, SAN ...sdaq: MDVN ) today announced that data from an on...vel androgen receptor antagonist,MDV3100, showed e...ining,serum levels of prostate specific antigen (P...
Other Medicine Technology:Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 2Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 3Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 4Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 5Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 6Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 7Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 8Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration-Resistant Prostate Cancer Patients at 44th ASCO Annual Meeting 2Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration-Resistant Prostate Cancer Patients at 44th ASCO Annual Meeting 3Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration-Resistant Prostate Cancer Patients at 44th ASCO Annual Meeting 4
...reference laboratory and a worldwide leader in inn...offers an extensive test menu of highly complex an...thology. Owned by the University of Utah, ARUP Lab...ation's university teaching hospitals and children...
...reference laboratory and a worldwide leader in inn...offers an extensive test menu of highly complex an...thology. Owned by the University of Utah, ARUP Lab...ation's university teaching hospitals and children...
...reference laboratory and a worldwide leader in inn...offers an extensive test menu of highly complex an...thology. Owned by the University of Utah, ARUP Lab...ation's university teaching hospitals and children...
...reference laboratory and a worldwide leader in inn...offers an extensive test menu of highly complex an...thology. Owned by the University of Utah, ARUP Lab...ation's university teaching hospitals and children...
Medicine Products: